Hong Kong stocks momentum | CanSino Biologics (06185.HK) rises over 4% again in the third quarter, with net profits more than 8 times higher year-on-year, and core product Convidecia sees significant growth.

According to the "Securities Times" app, Kangxinuo Biology (06185.HK) has risen by over 4% again, as of the time of publication, it has risen by 3.84%, to 45.98 Hong Kong dollars, with a turnover of 25.5136 million Hong Kong dollars.